BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MEDIAN Technologies Announces Two New Project Awards For A Total Amount Of €410,000


11/27/2013 9:53:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sophia Antipolis, France – November 27, 2013 – MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, today announced that it has been selected to provide imaging solutions and services in two phase II clinical trials for Hepatocellular Carcinoma (HCC). These two trials are sponsored by a global biopharmaceutical company.

As part of the projects, imaging data would be acquired in 55 clinical sites based in 5 Asian and 5 European countries. Anticipated total enrollment would be 210 patients with forecasted clinical trial starts in early 2015.

For the first study, MEDIAN will provide imaging services, enabling imaging data collection and quality control. For the second study, MEDIAN will also provide image independent review services performed by radiologists using the MEDIAN LMS platform. MEDIAN LMS is a unique solution for the review of images and quantitative assessment of response to therapy in clinical trials.

The anticipated amount for the two projects, awarded through MEDIAN alliance with its strategic CRO partner, is € 410,000 (eq. $ 554,000).

“We are proud of these new successes in Europe and Asia as it demonstrates the trust our biopharmaceutical clients have in our worldwide operational capabilities” said Nicolas Dano, Director of Business Development Europe and Asia. Since the beginning of 2013, MEDIAN Technologies has recorded €4.3M (eq. $5.8 M) of orders, including €1,0M of firm orders and €3.3M of project awards*.

[*] A project award notifies a company that their solution has been selected for a given project. A binding contract is then signed within the 18 months following the award, upon confirmation of the upstream clinical results.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES